CHARACTERIZATION OF A SUBLINE OF P388 LEUKEMIA RESISTANT TO AMSACRINE - EVIDENCE OF ALTERED TOPOISOMERASE-II FUNCTION
- 1 July 1987
- journal article
- research article
- Vol. 32 (1) , 17-25
- https://doi.org/10.1016/s0026-895x(25)13754-1
Abstract
Sensitive (P388/S) and amsacrine-resistant (P388/amsacrine) sublines of P388 leukemia were cloned in vitro and tested for differential chemosensitivity against a panel of drugs. P388/amsacrine, resistant both in vivo and in vitro to amsacrine, was cross-resistant to other putative topoisomerase II inhibitors including teniposide, etoposide, bisantrene, and doxorubicin. P388/amsacrine, was however, as sensitive as cloned P388/S to camptothecin, an inhibitor of topoisomerase I. The pattern of cross-resistance suggested that an alteration in topoisomerase II may be involved in the resistance of P388/amsacrine to these drugs. No differences in the uptake of amsacrine were detected between the two sublines. Cross-resistance to vinblastine was evident in P388/amsacrine; however resistance to vinblastine was associated with alterations in uptake or efflux of the drug. The number of protein-concealed single-strand breaks induced in whole cells by amsacrine, teniposide, bisantrene, and camptothecin was measured. Diminished numbers of strand breaks in the resistant subline were consistent with decreases in DNA-protein crosslinks. In the absence of drug treatment, resistant cells sustained approximately one-half as many single-strand breaks and DNA-protein crosslinks as the sensitive cells during preparation of nuclei. As measured by the P4 phage DNA unknotting assay, 0.35 M NaCl nuclear extracts from P388/S contained approximately 2.3-fold more topoisomerase II catalytic activity than did extracts from P388/amsacrine. The amount of protein that immunoreacted with a specific antibody to calf thymus topoisomerase II was also decreased in the resistant cells. These data suggest that alterations in topoisomerase II which lead to differential drug sensitivities are partially responsible for the resistance of P388/amsacrine to a specific group of drugs.This publication has 40 references indexed in Scilit:
- Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4′-(9-acridinylamino)-methanesulfon-m-anisidideEuropean Journal of Cancer and Clinical Oncology, 1982
- Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino)methanesulfon-m-anisidide and adriamycinBiochemistry, 1981
- OVERCOMING OF VINCRISTINE RESISTANCE IN P388 LEUKEMIA INVIVO AND INVITRO THROUGH ENHANCED CYTO-TOXICITY OF VINCRISTINE AND VINBLASTINE BY VERAPAMIL1981
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Qualitative and quantitative aspects of intercalator-induced DNA strand breaksBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1979
- ALTERED SURFACE-MEMBRANE GLYCOPROTEINS IN VINCA ALKALOID-RESISTANT HUMAN-LEUKEMIC LYMPHOBLASTS1979
- Protein-associated DNA breaks in cells treated with adriamycin or ellipticineBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1978
- DNA-binding characteristics of acridinylmethanesulphonanilide drugs: Comparison with antitumour propertiesPublished by Elsevier ,1976
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y)Biochemical Pharmacology, 1968